Literature DB >> 11058225

Cellular localization of lipocalin-type prostaglandin D synthase (beta-trace) in the central nervous system of the adult rat.

C T Beuckmann1, M Lazarus, D Gerashchenko, A Mizoguchi, S Nomura, I Mohri, A Uesugi, T Kaneko, N Mizuno, O Hayaishi, Y Urade.   

Abstract

We applied high-resolution laser-scanning microscopy, electron microscopy, and non-radioactive in situ hybridization histochemistry to determine the cellular and intracellular localization of lipocalin-type prostaglandin D synthase, the major brain-derived protein component of cerebrospinal fluid, and its mRNA in leptomeninges, choroid plexus, and parenchyma of the adult rat brain. Both immunoreactivity and mRNA for prostaglandin D synthase were located in arachnoid barrier cells, arachnoid trabecular cells, and arachnoid pia mater cells. Furthermore, meningeal macrophages and perivascular microglial cells, identified by use of ED2 antibody, were immunopositive for prostaglandin D synthase. In the arachnoid trabecular cells, the immunoreactivity for prostaglandin D synthase was located in the nuclear envelope, Golgi apparatus, and secretory vesicles, indicating the active production and secretion of prostaglandin D synthase. In the meningeal macrophages, prostaglandin D synthase was not found around the nucleus but in lysosomes in the cytoplasm, pointing to an uptake of the protein from the cerebrospinal fluid. Furthermore, the existence of meningeal cyclooxygenase (COX) -1 and COX-2 was investigated by Western blot, Northern blot, and reverse transcriptase-polymerase chain reaction (RT-PCR), and the colocalization of COX-2 and prostaglandin D synthase was demonstrated in virtually all cells of the leptomeninges, choroid plexus epithelial cells, and perivascular microglial cells, suggesting that these cells synthesize prostaglandin D(2) actively. Alternatively, oligodendrocytes showed prostaglandin D synthase immunoreactivity without detectable COX-2. The localization of lipocalin-type prostaglandin D synthase in meningeal cells and its colocalization with COX-2 provide evidence for its function as a prostaglandin D(2)-producing enzyme. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058225     DOI: 10.1002/1096-9861(20001204)428:1<62::aid-cne6>3.0.co;2-e

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  29 in total

1.  Prostaglandin D2 synthase/GPR44: a signaling axis in PNS myelination.

Authors:  Amelia Trimarco; Maria Grazia Forese; Valentina Alfieri; Alessandra Lucente; Paola Brambilla; Giorgia Dina; Damiana Pieragostino; Paolo Sacchetta; Yoshihiro Urade; Brigitte Boizet-Bonhoure; Filippo Martinelli Boneschi; Angelo Quattrini; Carla Taveggia
Journal:  Nat Neurosci       Date:  2014-11-02       Impact factor: 24.884

2.  Lipocalin-type prostaglandin D2 synthase protein regulates glial cell migration and morphology through myristoylated alanine-rich C-kinase substrate: prostaglandin D2-independent effects.

Authors:  Shinrye Lee; Eunha Jang; Jong-Heon Kim; Jae-Hong Kim; Won-Ha Lee; Kyoungho Suk
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

3.  Virus-induced inflammasome activation is suppressed by prostaglandin D2/DP1 signaling.

Authors:  Rahul Vijay; Anthony R Fehr; Ann M Janowski; Jeremiah Athmer; Dorthea L Wheeler; Matthew Grunewald; Ramakrishna Sompallae; Samarchith P Kurup; David K Meyerholz; Fayyaz S Sutterwala; Shuh Narumiya; Stanley Perlman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

Review 4.  Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Authors:  Conrad E Johanson; John A Duncan; Edward G Stopa; Andrew Baird
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

5.  Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid.

Authors:  Takahisa Kanekiyo; Tadato Ban; Kosuke Aritake; Zhi-Li Huang; Wei-Min Qu; Issay Okazaki; Ikuko Mohri; Shigeo Murayama; Keiichi Ozono; Masako Taniike; Yuji Goto; Yoshihiro Urade
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-02       Impact factor: 11.205

Review 6.  Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.

Authors:  S Ferré; I Diamond; S R Goldberg; L Yao; S M O Hourani; Z L Huang; Y Urade; I Kitchen
Journal:  Prog Neurobiol       Date:  2007-05-01       Impact factor: 11.685

7.  Enteric glia modulate epithelial cell proliferation and differentiation through 15-deoxy-12,14-prostaglandin J2.

Authors:  Kalyane Bach-Ngohou; Maxime M Mahé; Philippe Aubert; Hind Abdo; Sébastien Boni; Arnaud Bourreille; Marc G Denis; Bernard Lardeux; Michel Neunlist; Damien Masson
Journal:  J Physiol       Date:  2010-05-17       Impact factor: 5.182

8.  Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrier.

Authors:  Kazuto Yasuda; Cynthia Cline; Peter Vogel; Mihaela Onciu; Soghra Fatima; Brian P Sorrentino; Ranjit K Thirumaran; Sean Ekins; Yoshihiro Urade; Ko Fujimori; Erin G Schuetz
Journal:  Drug Metab Dispos       Date:  2013-01-08       Impact factor: 3.922

Review 9.  Meningiomas from a developmental perspective: exploring the crossroads between meningeal embryology and tumorigenesis.

Authors:  Julien Boetto; Matthieu Peyre; Michel Kalamarides
Journal:  Acta Neurochir (Wien)       Date:  2020-11-20       Impact factor: 2.216

10.  Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase.

Authors:  Daisuke Irikura; Kosuke Aritake; Nanae Nagata; Toshihiko Maruyama; Shigeru Shimamoto; Yoshihiro Urade
Journal:  J Biol Chem       Date:  2009-01-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.